Biotech firm Windtree Therapeutics plans to purchase up to $700 million of BNB following the cryptocurrency's recent all-time high. The company, listed on Nasdaq under the ticker WINT, aims to leverage an additional $520 million in funding mostly through a $500 million equity line of credit and a $20 million stock purchase agreement. This follows earlier announcements of a $200 million BNB investment. Windtree will partner with crypto exchange Kraken for asset custody as part of its plan to bolster its balance sheet with digital currencies. BNB, the fifth-largest cryptocurrency, recently peaked at $808 before a slight drop, currently trading at around $769, with a market cap of approximately $106.9 billion. This trend highlights a growing movement among publicly traded companies, including others like Nano Labs, to acquire digital assets to enhance their financial position, similar to the strategy employed by firms like MicroStrategy that focus heavily on Bitcoin.

Source đź”—